Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-04-12 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and references the German Securities Trading Act (WpHG) regarding the notification of the acquisition of voting rights by Kynam Capital Management, LP. This content directly relates to changes in significant share ownership thresholds and the intentions of major shareholders, which aligns perfectly with the definition of a Major Shareholding Notification (MRQ). Although the title mentions 'Voting Rights Announcements', the content details the notification of voting rights acquisition/holding, which is the core function of an MRQ filing in many jurisdictions, or closely related to it. Given the specific nature of reporting voting rights changes by an external entity, MRQ is the most precise fit among the provided codes, as DVA is typically for the *results* of a vote, not the notification of holding/acquisition thresholds.
2024-04-12 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Notification of Major Holdings' and details changes in voting rights percentages held by DWS Investment GmbH in MorphoSys AG, referencing specific sections of the German Securities Trading Act (WpHG). This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of a Major Shareholding Notification. The document header also mentions 'Voting Rights Announcements', which aligns with the content, but the specific structure and content match the 'Major Shareholding Notification' category (MRQ) more precisely than the general 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which typically covers the outcome of a vote, not routine holding changes. Since MRQ is available, it is the most appropriate classification.
2024-04-12 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a specific entity (Ministry of Finance on behalf of the State of Norway/Norges Bank). It details the percentage of voting rights attached to shares and instruments, crossing specific thresholds (3% and 5%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although the document mentions 'Voting Rights Announcements' in the header, the content structure (reporting thresholds crossed, direct/indirect holdings, ISINs) aligns perfectly with the 'Major Shareholding Notification' category (MRQ) rather than the general 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which typically reports the outcome of a vote already taken. Given the specific nature of tracking ownership thresholds crossing, MRQ is the most precise fit.
2024-04-12 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instruments held by a major shareholder (Morgan Stanley) in MorphoSys AG, referencing German Securities Trading Act (WpHG) articles. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The code for this is MRQ.
2024-04-12 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly contains a 'Notification of Major Holdings' section detailing changes in voting rights percentages (crossing thresholds) by a shareholder (Ministry of Finance on behalf of the State of Norway). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. The filing code for this is MRQ.
2024-04-12 English
MorphoSys Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
M&A Activity Classification · 1% confidence The document is a press release dated April 11, 2024, announcing that MorphoSys' Management Board and Supervisory Board recommend shareholders accept a public takeover offer by Novartis. Key phrases include "Public Takeover Offer," "Mergers & Acquisitions/Disposal," and references to the German Securities Acquisition and Takeover Act (WpÜG). This content directly relates to a proposal for one company to acquire another, which falls under the definition of M&A Activity (TAR). Although it mentions filing documents like Schedule TO and Schedule 14D-9 with the SEC, the primary purpose of this specific document is the announcement and recommendation regarding the takeover bid itself, making TAR the most appropriate classification over a general regulatory filing (RNS) or a proxy statement (PSI).
2024-04-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.